Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 1 of 1 | Showing Results 1 - 5 of 5

Natural History Study of the Development of Type 1 Diabetes.

(1) First degree relatives (age 1 – 45 years) of T1D probands. (2) Second and third degree relatives (age 1 – 20 years) of T1D probands: nieces,...

Erick Isaacson
  • Kadlec Diabetes Learning Center
  • Kadlec Research

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Elafibranor at Doses of 80 mg and 120mg After 12 Weeks of Treatment in Patients With Primary Biliary Cholangitis and Inadequate Response to Ursodeoxycholic Acid

Inclusion Criteria: Definite or probable PBC diagnosis as demonstrated by the presence of at least 2 of the following 3 diagnostic...

Kris Kowdley, M.D.
  • Swedish Medical Center

A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence...

Lisa Florence, M.D.
  • Swedish Medical Center

Evaluation of Acute Rejection Rates in de Novo Renal Transplant Recipients Following Thymoglobulin Induction, CNI-free, Nulojix (Belatacept)-Based Immunosuppression

Patients who undergo a kidney transplant require prolonged therapy with drugs that suppress the immune system (called immunosuppressive regimens)...

Marquis Hart, M.D.
  • Swedish Medical Center

Evaluating Childhood Cardiovascular Health Outcomes in NEPTUNE

This proposed ancillary study will investigate the following CVD risk factors in 150 children ? 21 years old with NS enrolled in the NEPTUNE or...

Katherine Tuttle, M.D.
  • Providence Health Care
  • Sacred Heart Medical Center & Children's Hospital
Viewing Page 1 of 1 | Showing Results 1 - 5 of 5